Study was a fixed-sequence, placebocontrolled, dose-titration, single-blind protocol intended to imitatetheclinicalmanagementofstatintherapy

Study was a fixed-sequence, placebocontrolled, dose-titration, single-blind protocol intended to imitatetheclinicalmanagementofstatintherapy(16).Allsubjects, independentofpriorcholesterol-loweringmedication,werefollowedforthree8weekphases:placebo,rosuvastatin5mg/day, androsuvastatin40mg/day.Therewasnowashoutperiodbetweenthephases.Thesubjectswereinstructedtotaketwotablets everymorning,i.e.,twoplacebotabletsduringthefirstphase;a single...

Irtuininhibitor.37 5.02sirtuininhibitor.three.81sirtuininhibitor.68 three.66sirtuininhibitor.48 3.61sirtuininhibitor.44 three.39sirtuininhibitor.Data are presented because the

Irtuininhibitor.37 five.02sirtuininhibitor.three.81sirtuininhibitor.68 three.66sirtuininhibitor.48 3.61sirtuininhibitor.44 3.39sirtuininhibitor.Information are presented because the mean sirtuininhibitorstandard deviation. aPsirtuininhibitor0.01 vs. the...